The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus-Reference-Cited by-同舟云学术

The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus

Author:

Park Eun-Jung¹,Kim Hyungjin²,Jung Seung Min³,Sung Yoon-Kyoung⁴,Baek Han Joo⁵^ORCID,Lee Jisoo⁶^ORCID

Affiliation:

1. Division of Rheumatology, Department of Medicine, National Medical Center, Seoul, Korea.

2. Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

3. Division of Rheumatology, Department of Medicine, Yonsei University College of Medicine, Seoul, Korea.

4. Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.

5. Division of Rheumatology, Department of Internal Medicine, Gachon University College of Medicine Gil Medical Center, Incheon, Korea.

6. Division of Rheumatology, Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea.

Publisher

Korean College of Rheumatology

Link

Reference176 articles.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献